Cyxone announced that the company's board has dismissed Tara Heitner from the company with immediate effect. Carl-Magnus Högerkorp, COO, will be acting as interim CEO. Tara Heitner has been the CEO at the company since 2020.

During this time, she has successfully developed the company from a virtual lean research company to a growing company with several clinical development projects which are engaging potential licensing partners.